Transdermal Transfersome Nanogels Control Hypertrophic Scar Formation via Synergy of Macrophage Phenotype‐Switching and Anti‐Fibrosis Effect
Advanced Science · 2024
DOI: 10.1002/advs.202305468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yunsheng Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn, Shanghai Burn Institute, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025…. Hauptthemen laut MEDLINE: Cicatrix, Hypertrophic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Health Industry Clinical Research Special Project, Shanghai Municipal Key Clinical Specialty.
Abstract (Originalsprache)
Hypertrophic scar (HS), which results from prolonged inflammation and excessive fibrosis in re‐epithelialized wounds, is one of the most common clinical challenges. Consequently, sophisticated transdermal transfersome nanogels (TA/Fu‐TS) are prepared to control HS formation by synergistically inhibiting inflammation and suppressing fibrosis. TA/Fu‐TSs have unique structures comprising hydrophobic triamcinolone acetonide (TA) in lipid multilayers and hydrophilic 5‐fluorouracil in aqueous cores, and perform satisfactorily with regard to transdermal co‐delivery to macrophages and HS fibroblasts in emerging HS tissues. According to the in vitro / vivo results, TA/Fu‐TSs not only promote macrophage phenotype‐switching to inhibit inflammation by interleukin‐related pathways, but also suppress fibrosis to remodel extracellular matrix by collagen‐related pathways. Therefore, TA/Fu‐TSs overcome prolonged inflammation and excessive fibrosis in emerging HS tissues, and provide an effective therapeutic strategy for controlling HS formation via their synergy of macrophage phenotype‐switching and anti‐fibrosis effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burn, Shanghai Burn Institute, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China.
- Department of Burn and Plastic Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
- Shunyi Maternal and Children's Hospital of Beijing Children's Hospital, Beijing, 101300, China.
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, 639 Zhizaoju Rd, Shanghai, 200011, China.
- Hongqiao International Institute of Medicine, Tongren Hospital, School of Medicine, Shanghai Jiao Tong University, 1111 XianXia Road, Shanghai, 200336, China.
- Department of Ear Reconstruction, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 33 Badachu Road, Beijing, 100144, China.
ORCID-Profile: Yunsheng Chen
Förderung
- National Natural Science Foundation of China
- Shanghai Health Industry Clinical Research Special Project
- Shanghai Municipal Key Clinical Specialty
Zitieren
APA
Chen, Y., Chen, K., Zhong, S., Wang, J., Yu, Z., Sun, X., Wang, Y., Liu, Y., & Zhang, Z. (2024). Transdermal Transfersome Nanogels Control Hypertrophic Scar Formation via Synergy of Macrophage Phenotype‐Switching and Anti‐Fibrosis Effect. Advanced Science. https://doi.org/10.1002/advs.202305468
Vancouver
Chen Y, Chen K, Zhong S, Wang J, Yu Z, Sun X, et al. Transdermal Transfersome Nanogels Control Hypertrophic Scar Formation via Synergy of Macrophage Phenotype‐Switching and Anti‐Fibrosis Effect. Advanced Science. 2024. doi:10.1002/advs.202305468
BibTeX
@article{Chen2024,
author = {Chen, Yunsheng and Chen, Kun and Zhong, Shan and Wang, Jiaqiang and Yu, Zhixi and Sun, Xiyang and Wang, Yue and Liu, Yan and Zhang, Zheng},
title = {Transdermal Transfersome Nanogels Control Hypertrophic Scar Formation via Synergy of Macrophage Phenotype‐Switching and Anti‐Fibrosis Effect},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202305468}
}
EUVIMED